Palentin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Palentin

What is Palentin?

Palentin is a prescription-only antibacterial medication used to combat a range of infections caused by susceptible bacteria. It is defined as a specialized semisynthetic combination antibiotic, specifically classified in the pharmacological group known as a β-Lactam/β-Lactamase Inhibitor Combination.

Quick Facts
Active Ingredients Amoxicillin, Clavulanic Acid
Form Tablet, Liquid Suspension, IV Injection
Pharmacological Class β-Lactam/β-Lactamase Inhibitor Combination
General Purpose Treatment of bacterial infections
Origin Semisynthetic

What Type of Medicine is Palentin?

Palentin, chemically identified as Amoxicillin/Clavulanic Acid, is a combination antibiotic designed to eliminate bacteria responsible for infections; it is not effective against viral illnesses like the common cold or flu. Its classification as a β-Lactam/β-Lactamase Inhibitor Combination signifies that it contains two distinct active components working together to address microbial resistance. The medicine is available for oral administration (as tablets and liquid suspension) and also in a preparation for intravenous use, allowing for flexible treatment across different patient needs.


What is Palentin Made Of, and How Does its Composition Work?

Palentin is a fixed-dosage combination product containing the antibiotic Amoxicillin and the protective ingredient Clavulanic Acid (often prepared as Clavulanate Potassium). Amoxicillin is the primary agent, a semisynthetic penicillin derivative that kills bacteria by disrupting their cell wall structure. This dual composition ensures Amoxicillin remains effective against strains that have developed resistance. The combination is used for targeting resistant bacteria effectively. Clavulanic Acid serves a crucial protective role; it is an inhibitor that neutralizes specific enzymes, known as β-lactamases, which some resistant bacteria produce to destroy the Amoxicillin.


Why is Palentin Considered a Broad-Spectrum Antibiotic?

Palentin is designated as a broad-spectrum antibiotic because the inclusion of Clavulanic Acid extends the range of bacteria that the drug can effectively target. This protection against bacterial β-lactamase enzymes means that Palentin can treat infections caused by strains that have developed resistance to Amoxicillin alone, such as those found in cases of sinusitis or certain skin infections. This combination serves as a therapy against numerous bacterial pathogens, playing a role in medical practice for treating a wide array of bacterial infections.

Regulatory References

  1. U.S. National Library of Medicine
  2. NCBI Bookshelf: Clavulanic Acid

What side effects are possible with Palentin?

Possible side effects and safety information

The safety profile of Palentin (Amoxicillin/Clavulanic Acid) is officially classified by regulatory bodies based on the frequency and the System-Organ Class affected. The most frequently reported adverse event is Diarrhoea, which is categorized as a Very Common effect in clinical use. Other Common effects include nausea, vomiting, and mucocutaneous candidiasis (yeast infection).

Reactions categorized as Uncommon typically involve the skin (e.g., rash and pruritus) and the hepatobiliary system, where rises in liver enzymes (AST/ALT) have been observed. Rare adverse reactions include effects on the nervous system, such as convulsions, which are more likely when high doses are administered or in patients with impaired kidney function.

Serious Adverse Reactions and Safety Constraints

Official labeling highlights the risk of Serious Adverse Reactions, including potentially fatal hypersensitivity reactions like Anaphylaxis and severe Cutaneous Adverse Reactions (SCAR). Serious reactions affecting the liver, such as Hepatitis and Cholestatic Jaundice, are also documented, with hepatic symptoms sometimes appearing several weeks after treatment has stopped.

Specific safety constraints exist for particular patient populations. Palentin is contraindicated in individuals with a history of severe hypersensitivity to any penicillin or other beta-lactam agent. Furthermore, its use is contraindicated in patients with a history of Palentin-associated cholestatic jaundice or hepatic dysfunction. Dose adjustments are required for patients with renal impairment, and the medicine is generally avoided in cases of suspected Infectious Mononucleosis.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Palentin is a medical emergency that can rapidly lead to life-threatening respiratory depression, coma, and death. Because of the drug's high potency, accidental ingestion, especially by children, can be fatal.

Documented Signs of Overdose

Official regulatory documents describe a cluster of signs strongly indicative of an opioid overdose. These symptoms include:

  • Respiratory Distress: Breathing that is slow, shallow, or stopped (respiratory failure).
  • Central Nervous System (CNS) Effects: Stupor, loss of consciousness, unresponsiveness, or coma.
  • Pupillary Changes: Pinpoint pupils (miosis).
  • Skin Changes: Cold and clammy skin, and cyanosis (blue discoloration of the lips, nails, or skin) indicating a lack of oxygen.

When to Seek Immediate Medical Help

The presence of severe symptoms, particularly the triad of coma, pinpoint pupils, and respiratory depression, requires urgent action. If an overdose is suspected, call 911 immediately for emergency medical assistance.

Emergency Response

Management of a Palentin overdose is primarily supportive and aims to rapidly reverse life-threatening respiratory depression. The documented emergency treatments include:

  • Naloxone Administration: The opioid antagonist naloxone is essential for reversing the effects of the overdose, and multiple doses may be required.
  • Ventilatory Support: Early and concurrent introduction of assisted breathing or ventilator support is critical to ensure oxygen delivery and prevent death from respiratory failure.

Therapeutic Uses of Palentin

What Palentin Treats: Main Uses and Benefits

Palentin is a medicine used to manage infections caused by susceptible bacteria across several key organ systems. It is relevant for conditions presenting with acute symptoms related to inflammatory or irritative states. It is applied in addressing conditions like acute bacterial sinusitis, otitis media (ear infection), community-acquired pneumonia, and infections of the skin and urinary tract.


Easing Symptom Burden Across Therapeutic Domains

Palentin is used for managing conditions characterized by acute bacterial infections, particularly in clinical settings that involve acute or unstable symptom patterns. It provides therapeutic support relevant to conditions presenting with heightened physiological activity, and may be part of symptomatic management for symptoms like fever, painful urination, earache, and localized swelling. This medicine is also applied in managing symptomatic infections of the skin and underlying tissues, such as cellulitis and abscesses, and in addressing odontogenic (dental) infections. Its use is relevant when supportive symptom management is appropriate, offering support that helps reduce the overall symptom burden.

Quick Fact: Supportive Management for Acute Discomfort
Symptom Axis Symptoms related to physical discomfort and systemic imbalance.
Clinical Context Applied in scenarios where additional management of discomfort is required.
Patient Benefit Contributes to easing the overall symptom load.

Eligibility and Restrictions for Use

Who Can and Cannot Use Palentin?

The eligibility for Palentin is strictly defined by regulatory documents, establishing clear non-eligibility rules and conditions for use based on patient health status and demographics.

Absolute Contraindications

Palentin is strictly contraindicated for use in two primary population groups:

  • History of Hypersensitivity: Patients with a documented history of serious allergic reactions (hypersensitivity) to penicillins, cephalosporins, or other beta-lactam antibacterial drugs.
  • Previous Drug-Induced Injury: Patients with a prior history of cholestatic jaundice or hepatic dysfunction specifically associated with Amoxicillin/Clavulanic Acid treatment.

Populations Requiring Conditional or Restricted Use

Official labeling requires restrictions or careful consideration for several groups:

  • Organ Function Restrictions: Patients with severe renal impairment ( CrCl < 30 mL/min) and those on hemodialysis are prohibited from using certain high-dose or extended-release formulations; standard forms require mandatory dose adjustment. Hepatic function must be monitored at regular intervals in patients with hepatic impairment.
  • Comorbidity: Use must be avoided if infectious mononucleosis is suspected, due to the high risk of developing a morbilliform skin rash.
  • Age and Weight: Adults and children ge 40 kg are eligible for standard tablets. Children weighing < 40 kg are not recommended to use adult tablets and must be treated with specialized weight-based oral suspension or sachet formulations.
  • Pregnancy and Lactation: Palentin is classified as FDA Pregnancy Category B; use is conditional and permitted only if clearly needed. During lactation, components pass into breast milk, and official guidance advises monitoring the infant for side effects.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Palentin (Amoxicillin/Clavulanic Acid) is defined by its pharmacokinetic effects on renal clearance and specific pharmacodynamic outcomes. Regulatory documentation formally establishes that Palentin may interfere with the systemic exposure and effects of other medicines.


Documented Pharmacokinetic and Pharmacodynamic Interactions

Interacting Substance Interaction Classification & Official Outcome
Probenecid Transporter-Mediated (PK): Inhibits renal tubular secretion, resulting in increased and prolonged Amoxicillin plasma concentrations.
Methotrexate Transporter-Mediated (PK): Reduces Methotrexate renal excretion, leading to increased serum concentrations and potential for increased toxicity.
Oral Anticoagulants Pharmacodynamic (PD): Has been reported to cause prolongation of prothrombin time and increased INR.
Allopurinol Pharmacodynamic (PD): Co-administration is associated with an increased likelihood of allergic skin reactions.

Administration and Population Constraints

The regulatory label includes specific constraints on co-administration and timing. The use of Live Attenuated Typhoid Vaccine (Oral) is generally not recommended, as Palentin may inactivate the live bacterial component of the vaccine. For optimal absorption and reduced gastrointestinal effects, administration is formally recommended at the start of a light meal. Additionally, the interaction with oral anticoagulants is noted as requiring increased monitoring in the elderly and patients with hepatic impairment or uremia.

Mechanism of Action

The Dual Mechanism of Action: Cell Wall Destruction and Enzymatic Protection

Palentin employs a coordinated, two-pronged approach to inactivate bacteria, focusing entirely on molecular mechanisms within the pathogen. The core action involves Amoxicillin binding irreversibly to bacterial Penicillin-Binding Proteins (PBPs), which are the essential enzymes required for building the bacterial cell wall's rigid structure . This binding immediately halts the final step of peptidoglycan cross-linking, leading to catastrophic structural failure and the rapid lysis (rupture and death) of the bacterial cell—a direct bactericidal effect.

Overcoming Bacterial Resistance through Suicide Inhibition

To enable the primary cell-killing action, Clavulanic Acid acts as a crucial enzyme inhibitor. Many resistant bacteria produce beta-Lactamase enzymes that chemically destroy Amoxicillin before it can reach its PBP targets. Clavulanic Acid works as a suicide inhibitor, preferentially binding to and irreversibly inactivating these beta-Lactamases. This specialized functional rescue prevents Amoxicillin from degradation, allowing the drug to inhibit PBPs against strains that would otherwise be protected by their defensive enzymes . The entire mechanism is contingent on two specific biological requirements: the presence of a peptidoglycan cell wall and the susceptibility of the beta-Lactamase enzyme class to Clavulanic Acid.

Dosage and Administration Information

How Palentin Is Used

Palentin (amoxicillin/clavulanic acid) is administered via oral and intravenous (IV) routes, with the chosen method depending on the severity of the infection and the patient's condition. The standard oral dosage for adults (≥ 40 kg) is typically 500 mg/125 mg or 875 mg/125 mg (amoxicillin/clavulanic acid), taken either twice daily (q12h) or three times daily (q8h). The extended-release formulation is prescribed as 2000 mg/125 mg every 12 hours.


Administration Requirements

Usage Requirement Instruction
Timing with Food Taken at the start of a meal to enhance absorption and minimize gastrointestinal effects.
Dosing Frequency Based on the formulation, dosing is scheduled every 8 or 12 hours, maintaining consistent intervals.
Course Duration The typical course length ranges from 5 to 10 days, and treatment is not extended beyond 14 days without re-evaluation.

Form and Population Restrictions

Usage involves specific procedural constraints based on the formulation. Extended-release tablets must be swallowed whole and cannot be crushed or chewed. Oral suspensions require reconstitution with water and must be shaken well before each dose.

Dose adjustments are required for patients with impaired kidney function (creatinine clearance ≤ 30 mL/min). In these patients, specific high-dose and extended-release formulations are restricted, and the frequency of administration is reduced. For pediatric patients (< 40 kg), dosing is calculated based on body weight (mg/kg/day) using the oral suspension.

Recent Clinical Evidence

Research evidence / Overview of studies

Overview of Clinical Research

Studies investigated compounds with specific activity toward inhibiting the reuptake of dopamine and norepinephrine, which is an area of interest in the study of ADHD and narcolepsy. Clinical trials were conducted to evaluate whether the combined effects of the drug were evaluated for their association with changes in symptoms over a 12-hour period. The scope of research involved both short-term (4-8 weeks) and long-term (up to 12 months) open-label extensions, primarily focusing on adult participants.


Key Findings in ADHD

Research has examined whether the drug was studied in relation to changes in attention and focus measures in individuals with ADHD.

  • Attention-Deficit Scores: Several studies evaluated the effect on scores from the ADHD Rating Scale (ADHD-RS). Findings documented a statistical difference in mean score changes compared to placebo groups across the trial duration.
  • Symptom Persistence: Studies investigated the pattern of symptom change over time. Observations suggested that the documented changes in attention scores were generally maintained during the 12-week core study period.

Key Findings in Narcolepsy

Trials assessed whether this medication was evaluated based on measurements of excessive daytime sleepiness in individuals with narcolepsy.

  • Wakefulness Measures: Research utilized the Multiple Sleep Latency Test (MSLT) and the Maintenance of Wakefulness Test (MWT) to assess potential changes in sleep parameters. The data has been analyzed to see if participants experienced a documented change in wakefulness.
  • Subjective Sleepiness: The Epworth Sleepiness Scale (ESS) was used to capture participant-reported changes. Analysis of ESS scores indicated statistical differences between the treatment and placebo groups.
  • Combination Research: Research has compared findings on wakefulness when using the combination versus the active ingredient alone.

Safety Profile

Clinical trial data documented adverse events and tolerability, and trial documentation discusses a history of cardiovascular issues relative to study inclusion criteria. Studies have explored whether the consumption of grapefruit juice is associated with an increase in the concentration of the drug in the blood, which could potentially affect the observation of side effects. Common adverse events documented in trials included dry mouth, insomnia, and anxiety.

Key Studies & References

  1. Review Article - :: Sleep Medicine Research (Review on Narcolepsy and ADHD shared symptoms and mechanisms)

Frequently Asked Questions (FAQ)

Common questions about Palentin (FAQ)


Q: Why is Palentin sometimes prescribed instead of Drug X?

A: Official documents describe Palentin as a combination of two active ingredients: Amoxicillin and Clavulanic Acid. This combination is recognized in official documents for the ability to address bacterial resistance caused by certain enzymes. This protective strategy enables Amoxicillin to function against a wider range of bacteria than Amoxicillin alone.

Q: Can I drink alcohol while taking Palentin?

A: Official patient information states that alcohol consumption is generally advised against during and for several days after treatment with Amoxicillin/Clavulanic Acid. This is a general safety recommendation.

Q: Are there any foods I need to avoid when using Palentin?

A: Official guidance recommends taking the medication at the start of a meal to enhance absorption and minimize the potential for stomach upset. There are generally no mandatory special dietary restrictions for this medicine. The importance of discussing all food concerns with a healthcare provider is noted in patient guidance.

Q: Does Palentin interact with herbal supplements like St. John's Wort?

A: Official labeling lists interactions with specific prescription drugs and vaccines. Patient guidance emphasizes the importance of providing a healthcare provider with a complete list of all medications and supplements being used, including herbal products, to assess potential risks.

Q: Is Palentin safe to use during pregnancy?

A: Palentin is classified by the FDA as Pregnancy Category B. This designation indicates that animal studies have generally shown no risk to the fetus. Use is permitted only when a healthcare provider determines it is clearly needed, based on a review of potential risks and patient circumstances.

Q: Is Palentin a controlled substance?

A: Palentin (Amoxicillin/Clavulanic Acid) is classified by regulatory bodies as a prescription-only antibacterial medication. It is not listed as a scheduled drug under the U.S. Controlled Substances Act.

Q: Does Palentin interact with birth control pills?

A: Official labeling notes that, in common with other broad-spectrum antibiotics, Palentin may reduce the efficacy of oral contraceptives. This is an important consideration that patients should discuss with their healthcare provider.

Q: Can Palentin be taken with coffee or caffeine?

A: Official instructions specify taking the medicine with food to aid absorption. There is no official interaction or avoidance guidance stated in regulatory documents specifically for general consumption of coffee or caffeine.

Q: Is Palentin safe to take if I have liver problems?

A: Palentin is contraindicated for patients with a history of Palentin-associated liver injury. For patients with pre-existing hepatic impairment (liver problems), official guidance notes that monitoring of liver function is necessary at regular intervals during treatment.

Q: Do I have to take Palentin at the same time every day?

A: Official instructions specify that the medicine should be taken at consistent intervals, such as every 8 hours or every 12 hours, to maintain effective concentration in the body. Following a routine helps to maintain these consistent intervals throughout the treatment course.

Q: What is Palentin chemically similar to?

A: The Amoxicillin component is classified as a semisynthetic penicillin derivative, which indicates a chemical relationship to penicillin antibiotics. The overall composition is a combination antibiotic.

Q: How quickly does Palentin start working?

A: The medicine's action is understood to begin shortly after the first dose. Official patient information indicates that a patient may begin to notice an improvement in their symptoms after about two to three days of starting the medication, though the rate can vary by infection.

Q: Do Palentin side effects usually go away after a while?

A: Many adverse reactions, particularly allergic and hematological effects, are documented in regulatory sources as being reversible upon discontinuation of therapy. If side effects persist or worsen, contact with a healthcare provider is indicated.

Q: Does Palentin cause weight gain?

A: Weight gain is not listed as a common, uncommon, or rare side effect in the official regulatory documents for Amoxicillin/Clavulanic Acid.

Q: Can Palentin make you feel tired or sleepy?

A: Official documents list adverse effects on the nervous system, including dizziness. Some patient information documents also mention tiredness or fatigue as a potential effect.

Q: What happens if I forget a dose of Palentin?

A: Official patient guidance describes taking the missed dose as soon as it is remembered, unless it is almost time for the next scheduled dose. It is stated that a double dose should not be taken to make up for a forgotten dose.

Q: What are known long-term side effects of Palentin?

A: Palentin is primarily intended for short-term use. Official labeling notes that serious effects affecting the liver, such as cholestatic jaundice, may sometimes be delayed and can appear several weeks after treatment has stopped. The long-term safety profile is based on the short duration of the drug’s use.

Q: How does Palentin affect driving or operating machinery?

A: Official documents note that due to the potential for nervous system effects, such as dizziness and convulsions, caution is warranted when driving or operating machinery until it is clear how the medicine affects the user.

Q: What is the difference between Palentin and its generic version?

A: Palentin is the brand name for the generic drug Amoxicillin and Clavulanate Potassium. Generic versions are approved by regulatory bodies to be bioequivalent, meaning they are required to provide similar amounts of the active ingredients in the bloodstream as the brand name product.

Q: Does taking Palentin require a special diet?

A: A special diet is not required. The main requirement is taking the medicine at the start of a meal to help improve absorption and minimize gastrointestinal effects, but there are no mandatory restrictions on specific food groups.

Q: What should I do if Palentin doesn't seem to be working for me?

A: If symptoms of the infection do not improve within a few days of starting the medication, or if they worsen, official guidance indicates that contact with a healthcare provider is necessary for medical review.

Q: Is Palentin used to treat anxiety?

A: Palentin is officially indicated and approved only for the treatment of specific bacterial infections. It is not indicated for the treatment of anxiety, although anxiety has been reported as a possible adverse reaction in clinical trial data.

Q: Why do doctors refer to Palentin using different drug names sometimes?

A: A medicine may have many brand names but only one official generic name. Doctors and pharmacists may use the official generic name, Amoxicillin/Clavulanic Acid, or other approved terms (like co-amoxiclav) because this is standard practice in medical communication.

Q: Is there a risk of becoming dependent on Palentin?

A: Dependence or addiction is not a risk recognized or documented by regulatory bodies for this antibacterial medication.

Q: Can Palentin affect your mood?

A: Official documents list anxiety and reversible hyperactivity as documented adverse reactions affecting the nervous system. These documented effects indicate potential changes in mood or emotional state.

Q: Does Palentin interact with heart medications?

A: Official labeling documents a specific interaction with oral anticoagulants, a type of heart medication. Co-administration of these drugs may increase the prolongation of prothrombin time, which suggests close monitoring is warranted.

Q: Is Palentin intended for short-term or long-term use?

A: The medicine is intended for short-term use. Treatment courses typically last between 5 and 10 days and are generally not recommended to be extended without a medical re-evaluation.

Q: Do different strengths of Palentin have different side effect profiles?

A: Clinical trial data has noted that high-dose and extended-release formulations show certain gastrointestinal effects, such as diarrhea, which may be more frequent than those reported with standard-dose formulations.

Q: How is Palentin absorbed by the body?

A: Both active components, Amoxicillin and Clavulanate, are well absorbed from the gastrointestinal tract following oral administration. Official guidance recommends that the medicine is taken with food to further aid this process.

Q: What is the half-life of Palentin?

A: Official pharmacokinetic data indicates that the elimination half-life is approximately 1.3 hours for Amoxicillin and approximately 1.0 hour for Clavulanic Acid in healthy adults. This figure describes the time it takes for the drug concentration in the body to be reduced by half.

How should Palentin be stored and disposed of?

Palentin (Amoxicillin/Clavulanic Acid) must be stored under specific conditions to maintain stability, with requirements varying by dosage form. The medicine must always be stored out of the reach of children.

Storage Element Official Requirement
Tablets/Dry Powder Controlled room temperature (below 77 F or 25 C). Store in the original container away from moisture and light.
Reconstituted Suspension Must be refrigerated at 36 F to 46 F (2 C to 8 C). Do not freeze.
In-Use Stability The mixed suspension must be discarded after 10 days of refrigeration.
Disposal Unused or expired medication should be disposed of via a drug take-back program. Do not flush down the toilet unless directed to by official guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Palentin found in:

A-Z Index: